A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancer.
Saved in:
| Title: | A cost-effectiveness study of PSMA-PET/CT for the detection of clinically significant prostate cancer. |
|---|---|
| Authors: | Privé BM; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands. Bastiaan.prive@radboudumc.nl.; Department of Radiation Oncology, Erasmus Medical Center, Cancer Institute, Rotterdam, The Netherlands. Bastiaan.prive@radboudumc.nl., Govers TM; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.; Medip Analytics, Nijmegen, The Netherlands., Israël B; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.; Department of Urology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.; Department of Radiation Oncology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Janssen MJR; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Timmermans BJR; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Peters SMB; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., de Groot M; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Zámecnik P; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Wijn SRW; Medip Analytics, Nijmegen, The Netherlands., Hoepping A; Department of Medicinal Chemistry, ABX Advanced Biochemical Compounds Gmbh, 1454, Radeberg, Germany., Sedelaar JPM; Department of Urology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Barentsz JO; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.; Department of Medical Imaging Andros Clinics, Arnhem, The Netherlands., van Oort IM; Department of Urology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., de Rooij M; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Nagarajah J; Department of Medical Imaging, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands. |
| Source: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2025 Jul; Vol. 52 (9), pp. 3159-3169. Date of Electronic Publication: 2025 Mar 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
